Charles Jakielaszek

<i>In Vitro</i> Activity of Gepotidacin, a Novel Triazaacenaphthylene Bacterial Topoisomerase Inhibitor, against a Broad Spectrum of Bacterial Pathogens

Douglas J. Biedenbach, S. Bouchillon, Meredith Hackel et al. · Antimicrobial Agents and Chemotherapy · 2016 · 139 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Bacteriologic Findings Associated with Chronic Bacterial Maxillary Sinusitis in Adults

S M Finegold, M. J. Flynn, Faina V. Rose et al. · Clinical Infectious Diseases · 2002 · 124 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Bacterial Resistance to Leucyl-tRNA Synthetase Inhibitor GSK2251052 Develops during Treatment of Complicated Urinary Tract Infections

Karen O’Dwyer, Aaron Spivak, Karen Ingraham et al. · Antimicrobial Agents and Chemotherapy · 2014 · 98 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study

Jonathan Ross, Janet Wilson, Kimberly Workowski et al. · The Lancet · 2025 · 67 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +6

Efficacy and Safety of Gepotidacin as Treatment of Uncomplicated Urogenital Gonorrhea (EAGLE-1): Design of a Randomized, Comparator-Controlled, Phase 3 Study

Caroline Perry, Nicole E. Scangarella-Oman, Helen Millns et al. · Infectious Diseases and Therapy · 2023 · 25 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12